Synthesis of novel entecavir analogues having 4′-cyano-6′′-fluoromethylenecyclopentene skeletons as an aglycone moiety as highly potent and long-acting anti-hepatitis B virus agent

Encouraged by our recent findings that 4′-cyano-deoxyguanosine (2), entecavir analogues 4 and 5 are highly potent anti-hepatitis B virus (HBV) agents, we designed and synthesized 6 having a hybridized structure of 4 and 5. The chiral quaternary carbon portion at the 4′-position, which is substituted by cyano- and 5′-hydroxymethyl groups, was stereospecifically constructed by radical-mediated 5-exo-dig mode cyclization of 10. The introduction of the fluorine atom into the 6′′-position was achieved by radical-mediated stannylation of sulfide (E)-11 and subsequent electrophilic fluorination of (E)-12. The desired (E)-6 was obtained after the introduction of the guanine base into (E)-18 under Mitsunobu conditions and following global deprotection. The stereoisomer (Z)-6 was also prepared by the same procedure using (Z)-12. Compound (E)-6 showed highly potent anti-HBV activity (EC50 = 1.2 nM) with favorable cytotoxicity (CC50 = 93 μM).

[1]  D. Venzon,et al.  Identification of a novel long-acting 4'-modified nucleoside reverse transcriptase inhibitor against HBV. , 2020, Journal of hepatology.

[2]  Chandralata Bal,et al.  Rhodium catalyzed stereospecific reductive carbocyclization of 1,6-enynes and synthesis of 4′-methyl-6′-substituted aristeromycins , 2019, Nucleosides, nucleotides & nucleic acids.

[3]  H. Mitsuya,et al.  Diastereoselective Synthesis of 6″-(Z)- and 6″-(E)-Fluoro Analogues of Anti-hepatitis B Virus Agent Entecavir and Its Evaluation of the Activity and Toxicity Profile of the Diastereomers. , 2016, The Journal of organic chemistry.

[4]  S. Sarafianos,et al.  4′‐modified nucleoside analogs: Potent inhibitors active against entecavir‐resistant hepatitis B virus , 2015, Hepatology.

[5]  M. Yuen,et al.  Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B. , 2011, The Journal of antimicrobial chemotherapy.

[6]  M. Nassal Hepatitis B viruses: reverse transcription a different way. , 2008, Virus research.

[7]  T. Sugimura,et al.  Di-2-methoxyethyl Azodicarboxylate (DMEAD): An Inexpensive and Separation-friendly Alternative Reagent for the Mitsunobu Reaction , 2007 .

[8]  Wei-kuan Li,et al.  An efficient Mitsunobu coupling to adenine-derived carbocyclic nucleosides , 2006 .

[9]  R. Grant,et al.  Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Colin W Shepard,et al.  Hepatitis B virus infection: epidemiology and vaccination. , 2006, Epidemiologic reviews.

[11]  S. Dey,et al.  Synthesis of tert-butoxycarbonyl (Boc)-protected purines. , 2000, The Journal of organic chemistry.

[12]  O. Mitsunobu The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis and Transformation of Natural Products , 1981 .

[13]  M. Nassal New insights into HBV replication: new opportunities for improved therapies , 2009 .

[14]  M. Tius,et al.  Rapid Fluorination of Alkenyl Stannanes with Silver Triflate and Xenon Difluoride , 1993 .